We have located links that may give you full text access.
COMPARATIVE STUDY
JOURNAL ARTICLE
Bronchodilator response in wheezing infants assessed by the raised volume rapid thoracic compression technique.
Respiratory Medicine 2016 October
BACKGROUND: Bronchodilator response (BDR) analyzed by the raised volume rapid thoracic compression (RVRTC) in wheezing infants is not yet well described, although bronchodilators (BD) are routine in the treatment of this population.
OBJECTIVE: To evaluate BDR by RVRTC technique in infants with recurrent wheezing and compare to control group.
METHOD: Cross sectional study, 45 infants, age 56 weeks (38-67 weeks). Two groups: wheezing group (WG: history of recurrent wheezing) and control group (CG). RVRTC was evaluated, FVC, FEV0.5 , FEF50 , FEF75 , FEF85, FEF25-75 were measured. Salbutamol was delivered to infants and RVRTC evaluated again. BDR was determined by the increase greater than two standard deviation from the mean change in the CG.
RESULTS: In WG (n = 32) lung function was worse than in CG (n = 13): FEV0.5 : 0.0(-0.9-0.9z score) vs 0.8(0.2-1.4z score); FEF50 : 0.2(-0.3-1.1z score) vs 0.9(0.5-1.4z score); and FEF25-75 : 0.2(-0.5-1.1z score) vs 1.1(0.6-1.6z score), respectively, p < 0.05. Both groups had similar increase after BD. In WG 11 patients (34%) were responder and these had worse lung function compared to nonresponder (n = 21) (p < 0.05). The increase in lung function after BD in responder was higher than in nonresponder: FEV0.5 : 6.5(2.1-7.1%) vs -0.5(-2.5-0.7%), FEF50 : 5.1(2.7-11.7%) vs 0.4(-1.1-2.8%), FEF75 : 20.7(4.7-23.6%) vs -1.3(-6.4-3.9%), FEF25-75 : 9.9(3.8-16.4%) vs 0.0(-1.5-1.0%), respectively, p < 0.05.
CONCLUSION: 34% WG showed BDR measured by the RVRTC. The best variables to detect BDR were FEF75 , FEF25-75 and FEV0.5 . Patients with worse lung function showed better response to BD.
OBJECTIVE: To evaluate BDR by RVRTC technique in infants with recurrent wheezing and compare to control group.
METHOD: Cross sectional study, 45 infants, age 56 weeks (38-67 weeks). Two groups: wheezing group (WG: history of recurrent wheezing) and control group (CG). RVRTC was evaluated, FVC, FEV0.5 , FEF50 , FEF75 , FEF85, FEF25-75 were measured. Salbutamol was delivered to infants and RVRTC evaluated again. BDR was determined by the increase greater than two standard deviation from the mean change in the CG.
RESULTS: In WG (n = 32) lung function was worse than in CG (n = 13): FEV0.5 : 0.0(-0.9-0.9z score) vs 0.8(0.2-1.4z score); FEF50 : 0.2(-0.3-1.1z score) vs 0.9(0.5-1.4z score); and FEF25-75 : 0.2(-0.5-1.1z score) vs 1.1(0.6-1.6z score), respectively, p < 0.05. Both groups had similar increase after BD. In WG 11 patients (34%) were responder and these had worse lung function compared to nonresponder (n = 21) (p < 0.05). The increase in lung function after BD in responder was higher than in nonresponder: FEV0.5 : 6.5(2.1-7.1%) vs -0.5(-2.5-0.7%), FEF50 : 5.1(2.7-11.7%) vs 0.4(-1.1-2.8%), FEF75 : 20.7(4.7-23.6%) vs -1.3(-6.4-3.9%), FEF25-75 : 9.9(3.8-16.4%) vs 0.0(-1.5-1.0%), respectively, p < 0.05.
CONCLUSION: 34% WG showed BDR measured by the RVRTC. The best variables to detect BDR were FEF75 , FEF25-75 and FEV0.5 . Patients with worse lung function showed better response to BD.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app